A pilot study of cortical glutathione in youth with depression

[1]  Lihong Wang,et al.  Decreased Resting-State Activity in the Precuneus Is Associated With Depressive Episodes in Recurrent Depression. , 2017, The Journal of clinical psychiatry.

[2]  Andrew T. Drysdale,et al.  Resting-state connectivity biomarkers define neurophysiological subtypes of depression , 2016, Nature Medicine.

[3]  L. Kegeles,et al.  Brain γ‐aminobutyric acid (GABA) detection in vivo with the J‐editing 1H MRS technique: a comprehensive methodological evaluation of sensitivity enhancement, macromolecule contamination and test–retest reliability , 2016, NMR in biomedicine.

[4]  D. Pizzagalli,et al.  Assessing anhedonia in depression: Potentials and pitfalls , 2016, Neuroscience & Biobehavioral Reviews.

[5]  Melonie P. Heron,et al.  Deaths: Leading Causes for 2014. , 2016, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[6]  M. Berk,et al.  N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis. , 2016, The Journal of clinical psychiatry.

[7]  C. Correll,et al.  Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: results from a meta-analysis. , 2015, The Journal of clinical psychiatry.

[8]  Deepmala,et al.  Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review , 2015, Neuroscience & Biobehavioral Reviews.

[9]  Elizabeth B. Liddle,et al.  Dissociated large-scale functional connectivity networks of the precuneus in medication-naïve first-episode depression , 2015, Psychiatry Research: Neuroimaging.

[10]  D. Strong,et al.  Measuring Anhedonia in Adolescents: A Psychometric Analysis , 2015, Journal of personality assessment.

[11]  P. Cowen,et al.  Neurochemistry of major depression: a study using magnetic resonance spectroscopy , 2014, Psychopharmacology.

[12]  X. Mao,et al.  Motor cortex glutathione deficit in ALS measured in vivo with the J-editing technique , 2014, Neuroscience Letters.

[13]  Amy R. Johnson,et al.  In vivo 1H MRS study of potential associations between glutathione, oxidative stress and anhedonia in major depressive disorder , 2014, Neuroscience Letters.

[14]  Katherine Prater,et al.  Trait anhedonia is associated with reduced reactivity and connectivity of mesolimbic and paralimbic reward pathways. , 2013, Journal of psychiatric research.

[15]  N. Ryan,et al.  Neural response to reward as a predictor of increases in depressive symptoms in adolescence , 2013, Neurobiology of Disease.

[16]  C. Pittenger,et al.  N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial. , 2013, Journal of the American Academy of Child and Adolescent Psychiatry.

[17]  M. Filip,et al.  N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: Behavioral and biochemical analyses in rats , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[18]  R. Shelton,et al.  Oxidative stress and glutathione response in tissue cultures from persons with major depression. , 2012, Journal of psychiatric research.

[19]  Xiangling Mao,et al.  Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology , 2012, NMR in biomedicine.

[20]  A. Hardan,et al.  A Randomized Controlled Pilot Trial of Oral N-Acetylcysteine in Children with Autism , 2012, Biological Psychiatry.

[21]  B. Frey,et al.  Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder , 2012, Oxidative medicine and cellular longevity.

[22]  R. Kessler,et al.  Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. , 2012, Archives of general psychiatry.

[23]  Benjamin A. Ely,et al.  The possible role of the kynurenine pathway in anhedonia in adolescents , 2012, Journal of Neural Transmission.

[24]  L. Micheli,et al.  Oxidative species and S‐glutathionyl conjugates in the apoptosis induction by allyl thiosulfate , 2012, The FEBS journal.

[25]  Jun-Feng Wang,et al.  Prefrontal cortex glutathione S-transferase levels in patients with bipolar disorder, major depression and schizophrenia. , 2011, The international journal of neuropsychopharmacology.

[26]  R. Boles,et al.  Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[27]  E. Costello,et al.  Cumulative prevalence of psychiatric disorders by young adulthood: a prospective cohort analysis from the Great Smoky Mountains Study. , 2011, Journal of the American Academy of Child and Adolescent Psychiatry.

[28]  Michael Berk,et al.  N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. , 2011, Journal of psychiatry & neuroscience : JPN.

[29]  I. Bernstein,et al.  Psychometric properties of the Children's Depression Rating Scale-Revised in adolescents. , 2010, Journal of child and adolescent psychopharmacology.

[30]  K. Merikangas,et al.  Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A). , 2010, Journal of the American Academy of Child and Adolescent Psychiatry.

[31]  J. Babb,et al.  The possible role of the kynurenine pathway in adolescent depression with melancholic features. , 2010, Journal of child psychology and psychiatry, and allied disciplines.

[32]  M. Mintun,et al.  Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus , 2010, Proceedings of the National Academy of Sciences.

[33]  J. Babb,et al.  The kynurenine pathway in adolescent depression: Preliminary findings from a proton MR spectroscopy study , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[34]  M. Phillips,et al.  Healthy adolescents' neural response to reward: associations with puberty, positive affect, and depressive symptoms. , 2010, Journal of the American Academy of Child and Adolescent Psychiatry.

[35]  Scot Hickey,et al.  Impact of Teen Depression on Academic, Social, and Physical Functioning , 2009, Pediatrics.

[36]  B. Cumurcu,et al.  Total antioxidant capacity and total oxidant status in patients with major depression: Impact of antidepressant treatment , 2009, Psychiatry and clinical neurosciences.

[37]  L. Vávřová,et al.  Antioxidative enzymes and increased oxidative stress in depressive women. , 2009, Clinical biochemistry.

[38]  J. Yonkman,et al.  Transporting Children With Special Health Care Needs: Comparing Recommendations and Practice , 2009, Pediatrics.

[39]  Dennis S. Charney,et al.  Amino Acid Neurotransmitters Assessed by Proton Magnetic Resonance Spectroscopy: Relationship to Treatment Resistance in Major Depressive Disorder , 2009, Biological Psychiatry.

[40]  N. Banu,et al.  Induction of oxidative stress by restraint stress and corticosterone treatments in rats. , 2009, Indian journal of biochemistry & biophysics.

[41]  F. Guimarães,et al.  Antidepressant-like effects of N-acetyl-L-cysteine in rats , 2008, Behavioural pharmacology.

[42]  J. Piacentini,et al.  Pediatric emergency department suicidal patients: two-site evaluation of suicide ideators, single attempters, and repeat attempters. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.

[43]  Peter Muris,et al.  The assessment of anhedonia in clinical and non-clinical populations: further validation of the Snaith-Hamilton Pleasure Scale (SHAPS). , 2007, Journal of affective disorders.

[44]  Rolf Gruetter,et al.  Detection of an antioxidant profile in the human brain in vivo via double editing with MEGA‐PRESS , 2006, Magnetic resonance in medicine.

[45]  Sergio Tufik,et al.  Acute stressor-selective effects on homocysteine metabolism and oxidative stress parameters in female rats , 2006, Pharmacology Biochemistry and Behavior.

[46]  N. Duan,et al.  Depression and role impairment among adolescents in primary care clinics. , 2005, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[47]  J. Anthony,et al.  Child and adolescent clinical features as forerunners of adult-onset major depressive disorder: retrospective evidence from an epidemiological sample. , 2004, Journal of affective disorders.

[48]  Olga V. Demler,et al.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). , 2003, JAMA.

[49]  J. Yabut,et al.  Glutathione depletion and oxidative stress. , 2002, Parkinsonism & related disorders.

[50]  M. Bekaroǧlu,et al.  Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. , 2001, Journal of affective disorders.

[51]  R. Dringen,et al.  Metabolism and functions of glutathione in brain , 2000, Progress in Neurobiology.

[52]  C. Shaw,et al.  Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death , 1997, Brain Research Reviews.

[53]  N. Ryan,et al.  Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[54]  S. Mukherjee,et al.  Free radical pathology and antioxidant defense in schizophrenia: a review , 1996, Schizophrenia Research.

[55]  M. Hamilton,et al.  A Scale for the Assessment of Hedonic Tone the Snaith–Hamilton Pleasure Scale , 1995, British Journal of Psychiatry.

[56]  C. Büchel,et al.  The brain’s response to reward anticipation and depression in adolescence: dimensionality, specificity and longitudinal predictions in a community-based sample , 2015 .

[57]  M. Maes,et al.  Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression. , 2011, Neuro endocrinology letters.

[58]  M. Berk,et al.  Oxidative stress in psychiatric disorders : evidence base and therapeutic implications , 2008 .

[59]  J. Krystal,et al.  Impairment of GABAergic transmission in depression: new insights from neuroimaging studies. , 2000, Critical reviews in neurobiology.

[60]  D. Pine,et al.  Adolescent depressive symptoms as predictors of adult depression: moodiness or mood disorder? , 1999, The American journal of psychiatry.